| Cases | Positive cases (%) | ||||
---|---|---|---|---|---|---|
AFP | CEA | CA125 | CA19-9 | Qualitative combined | ||
Stage | Â | Â | Â | Â | Â | Â |
early stage | 30 | 1 (3.3) | 0 (0.0) | 2 (6.7) | 2 (6.7) | 4 (13.3) |
advanced stage | 119 | 6 (5.0) | 26 (21.8) | 19 (16.0) | 29 (24.4) | 56 (47.1) |
χ 2 |  | 0.156 | 7.940 | 1.711 | 4.557 | 11.330 |
P | Â | 1.000 | 0.005 | 0.249 | 0.042 | 0.001 |
Location | Â | Â | Â | Â | Â | Â |
cardia | 13 | 2 (15.4) | 5 (38.5) | 1 (7.7) | 6 (46.2) | 9 (69.2) |
gastric body | 61 | 0 (0.0) | 12 (19.7) | 10 (16.4) | 7 (11.5) | 21 (34.4) |
gastric antrum | 70 | 5 (7.1) | 9 (12.9) | 10 (14.3) | 18 (25.7) | 30 (42.9) |
multi-site | 5 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
χ 2 |  | 7.504 | 6.275 | 1.529 | 10.630 | 8.965 |
P | Â | 0.056 | 0.098 | 0.696 | 0.016 | 0.026 |
Differentiation | Â | Â | Â | Â | Â | Â |
high | 6 | 1 (16.7) | 1 (16.7) | 1 (16.7) | 2 (33.3) | 3 (50.0) |
moderate | 72 | 4 (5.6) | 12 (16.7) | 8 (11.1) | 13 (18.1) | 28 (38.9) |
poor | 71 | 2 (2.8) | 13 (18.3) | 12 (16.9) | 16 (22.5) | 29 (40.8) |
χ 2 |  | 2.599 | 0.070 | 1.024 | 1.031 | 0.303 |
P | Â | 0.268 | 0.930 | 0.735 | 0.605 | 0.839 |